Left ventricular mass and cardiac function in a population of children with chronic kidney disease

Francesca Mencarelli1, Marianna Fabi, Valentina Corazzi

  • 1Department of Pediatrics, Nephrology Unit, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 11, 40138, Bologna, Italy.

Insights

Tissue Doppler Imaging (TDI) aids in the early diagnosis of left ventricular diastolic dysfunction (LVDD) in children with chronic kidney disease (CKD), correlating with disease severity and risk factors.

Area of Science:

  • Pediatric Cardiology
  • Nephrology
  • Diagnostic Imaging

Background:

  • Cardiovascular disease (CVD) is a significant cause of illness and death in pediatric chronic kidney disease (CKD) patients.
  • Left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD) are early indicators of cardiac issues in this population.
  • Identifying cardiac complications early is crucial for managing pediatric CKD patients.

Purpose of the Study:

  • To assess LVH and LVDD in children with CKD using conventional echocardiography and Tissue Doppler Imaging (TDI).
  • To investigate the relationship between cardiac abnormalities and potential risk factors in pediatric CKD.
  • To determine the diagnostic accuracy of TDI compared to conventional echocardiography for LVDD.

Main Methods:

  • A cohort of 34 pediatric CKD patients and 34 healthy controls was studied.
  • Echocardiography, including TDI, was used to evaluate left ventricular structure and diastolic function.
  • Patients were categorized by CKD stage (2, 3, and 4-5), and LVH was defined by left ventricular mass index (LVMI).

Main Results:

  • Left ventricular hypertrophy (LVH) was observed in 38% of pediatric CKD patients.
  • Diastolic dysfunction, assessed by TDI (E'/A' ratio), worsened with declining kidney function (p=0.020).
  • LVMI positively correlated with body mass index, while E'/A' negatively correlated with phosphorus and calcium levels.

Conclusions:

  • Tissue Doppler Imaging (TDI) is a straightforward and potentially more accurate method for early LVDD diagnosis in children with CKD.
  • TDI can help identify early cardiac changes related to CKD progression and associated risk factors.
  • The findings underscore the importance of cardiac monitoring in pediatric CKD.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
337
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679